Evidence map›Paper›PMID 34334565›Full record

ArticleInternal medicine (Tokyo, Japan)2022

Endovascular Treatment for Lower-extremity Arterial Thrombosis in a Patient with Congenital Afibrinogenemia and a History of Bleeding Complications.

Daisuke Hiramatsu, Yoshito Ogihara, Takeshi Matsumoto, Kei Sato, Akihiro Takasaki, Tairo Kurita, Ryuji Okamoto, Hideo Wada, Kaoru Dohi

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Daisuke HiramatsuDepartment of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan.
Yoshito OgiharaDepartment of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan.
Takeshi MatsumotoDepartment of Transfusion Medicine and Cell Therapy, Mie University Hospital, Japan.
Kei SatoDepartment of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan.
Akihiro TakasakiDepartment of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan.
Tairo KuritaDepartment of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan.
Ryuji OkamotoDepartment of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan.
Hideo WadaDepartment of General and Laboratory Medicine, Mie Prefectural General Medical Center, Japan; Associated Department with Mie Graduate School of Medicine, Japan.
Kaoru DohiDepartment of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan.
Mie University · JPMie University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital afibrinogenemia is a rare autosomal recessive blood disorder that accompanies thrombotic complications and is associated with bleeding tendency. The management of these opposing complications remains a challenge. Endovascular treatment (EVT) for peripheral arterial thrombosis has not been described in previous studies. A 57-year-old man with congenital afibrinogenemia developed back pain and left lower leg pain. The cause of the pain was confirmed to be renal infarction and lower extremity arterial thrombosis by Doppler ultrasound and contrast-enhanced computed tomography. He was treated with EVT for the lower extremity arterial thrombosis, leading to an excellent short-term improvement without bleeding.

Indexed as

AfibrinogenemiaBlood Coagulation DisordersThrombosisExtremitiesHemorrhageHumansMaleMiddle Agedbleedingcongenital afibrinogenemiaendovascular treatmentperipheral arterial thrombosis

Identifiers

PMID34334565
PMCPMC8866793
OpenAlexW3192172380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.